Kronos Bio Inc reports results for the quarter ended in June - Earnings Summary

Kronos Bio

12/08/2021 22:39

* Kronos Bio Inc  KRON.OQ  reported a quarterly adjusted loss
of 53 cents​​ per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss
of 62 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Kronos Bio Inc's reported EPS for the quarter was a loss of 53
cents​.
* The mean earnings estimate of analysts had risen by
about 19.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Kronos Bio Inc shares had fallen by 18.1% this quarter and
lost 34.3% so far this year.
* The company reported a quarterly loss of $29.03 million.
* Wall Street's median 12-month price target for Kronos Bio Inc
is $41.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 09:39 p.m.  ​All
figures in US dollars unless otherwise stated